3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Specimen Handling
39
Magnetic Resonance Spectroscopy
27
Carboplatin
19
Gemcitabine
17
Biopsy
16
Cyclophosphamide
14
Cisplatin
14
pembrolizumab
13
fludarabine
13
Paclitaxel
13
Injections
12
Dexamethasone
12
Radiotherapy
10
Interviews as Topic
10
Oxaliplatin
9
Nivolumab
9
venetoclax
8
Irinotecan
8
Fluorouracil
8
Bevacizumab
8
X-Rays
7
Radiosurgery
7
Bortezomib
7
toripalimab
6
Rituximab
6
Pemetrexed
6
Drug Therapy
6
Doxorubicin
6
Capecitabine
6
Calcium Dobesilate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Infliximab
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled